Table V. Fifteen patients administered with ICI.
ICI, Immune checkpoint inhibitors; TMB, tumor mutation burden; CPS, combined positive score; BOR, best overall response; CGP, cancer genome profiling; SCC, squamous cell carcinoma; SDC, salivary duct carcinoma; ACC, adenoid cystic carcinoma; MM, malignant melanoma.